JGA President Sawai Insists on Keeping 70% Rule for New Generics

In an interview with Jiho, Inc. on October 18, Hiroyuki Sawai, president of the Japan Generic Medicines Association (JGA), stressed that the JGA’s firm position is that the 70% rule for pricing of new generics should be retained. The Central...read more